11.3 Critical Bradyarrhythmias, Conduction Blocks & Temporary Cardiac Pacing

ACLS Bradycardia Algorithm & Clinical Assessment

Bradycardia is defined as a heart rate $< 50\text{ bpm}$. In the intensive care unit, bradycardia is common and may represent a benign physiological adaptation (e.g., in trained athletes or during deep sleep) or a life-threatening conduction disturbance leading to profound hypoperfusion, cardiogenic shock, and cardiac arrest.

Clinical Assessment of Hemodynamic Compromise

The fundamental clinical imperative is determining whether bradycardia is producing acute end-organ hypoperfusion. An unstable, symptomatic bradycardia is defined by the presence of any of the following five cardinal features:

1. Systemic Hypotension: Systolic blood pressure $< 90\text{ mmHg}$ or mean arterial pressure $< 65\text{ mmHg}$.
2. Acutely Altered Mental Status: Confusion, lethargy, encephalopathy, or syncope from cerebral hypoperfusion.
3. Signs of Shock: Diaphoresis, cool mottled extremities, delayed capillary refill, oliguria, or rising serum lactate.
4. Ischemic Chest Discomfort: Angina or ischemic ST-segment deviations secondary to diminished coronary perfusion pressure.
5. Acute Heart Failure / Flash Pulmonary Edema: Bilateral rales, tachypnea, severe hypoxemia, and elevated jugular venous pressure.

                 ACLS BRADYCARDIA ALGORITHM (HR < 50 BPM)
                                    │
                 ┌──────────────────┴──────────────────┐
                 ▼                                     ▼
         STABLE PATIENT                        UNSTABLE PATIENT
  • Monitor and observe                 • Signs of shock, hypotension,
  • Identify underlying triggers          ischemia, altered mental status
  • Obtain 12-lead ECG                                 │
                                                       ▼
                                           FIRST-LINE: ATROPINE
                                           • 1 mg IV push q3-5 min (max 3 mg)
                                           • Ineffective in Mobitz II, wide 3rd
                                             degree block, & heart transplants
                                                       │
                                      ┌────────────────┴────────────────┐
                                      ▼                                 ▼
                            ATROPINE INEFFECTIVE               INFRANODAL BLOCK
                            • Transcutaneous Pacing (TCP)      • Prepare immediate
                            • IV Chronotropic Infusion:          Transvenous Pacing
                              - Dopamine: 5-20 mcg/kg/min        (TVP)
                              - Epinephrine: 2-10 mcg/min
                              - Isoproterenol: 2-10 mcg/min

Anatomical Level of Conduction Impairment

Understanding the anatomical level of the conduction block dictates therapeutic responsiveness and prognosis:

• Supra-Nodal and AV Nodal Blocks: Sinus bradycardia, sinoatrial exit block, sinus pause/arrest, and Second-Degree AV Block Type I (Mobitz I / Wenckebach). Conduction delay occurs within the sinus or AV node, which is heavily innervated by sympathetic and parasympathetic (vagal) fibers. The escape rhythm arises from the junction (narrow QRS, rate $40\text{--}60\text{ bpm}$), is hemodynamically stable, and responds promptly to vagolytic therapy (atropine).
• Infranodal Blocks (His-Purkinje System): Second-Degree AV Block Type II (Mobitz II) and Third-Degree (Complete) AV Block with wide QRS complexes ($> 120\text{ ms}$). Conduction failure occurs below the AV node within the bundle of His or bundle branches, which lack parasympathetic innervation. The escape pacemaker is ventricular (broad, bizarre QRS, rate $20\text{--}40\text{ bpm}$), intrinsically unstable, prone to sudden asystolic arrest, and completely refractory to atropine.

ICU Reversible Etiologies

• Acute Myocardial Infarction: Inferior MI (RCA occlusion) induces AV nodal ischemia or heightened vagal tone (Bezold-Jarisch reflex); typically transient and responds to atropine. Anterior MI (LAD septal perforator occlusion) causes extensive septal necrosis destroying both bundle branches, causing sudden, catastrophic infranodal complete AV block with a wide QRS, severe cardiogenic shock, and high mortality.
• Medications: Beta-adrenergic blockers, non-dihydropyridine calcium channel blockers, digoxin, amiodarone, clonidine, and dexmedetomidine.
• Metabolic Derangements: Severe hyperkalemia ($K^+ > 6.5\text{ mEq/L}$; sine waves, complete block), severe hypothermia ($< 32^\circ\text{C}$; Osborn J-waves), severe acidosis, profound hypoxemia, and severe hypothyroidism (myxedema coma).
• Intracranial Hypertension (Cushing Triad): Life-threatening elevation of intracranial pressure manifesting as severe bradycardia, systolic hypertension with widened pulse pressure, and irregular respirations.

---

Pharmacological Management of Symptomatic Bradycardia

First-Line Therapy: Intravenous Atropine

• Mechanism: Competitively blocks muscarinic $M_2$ acetylcholine receptors on the sinoatrial and atrioventricular nodes, abolishing parasympathetic vagal tone, accelerating SA node firing, and enhancing AV nodal conduction velocity.
• Dosing: Administer $1.0\text{ mg}$ rapid IV push every 3 to 5 minutes to a maximum cumulative dose of $3.0\text{ mg}$ (equivalent to $0.04\text{ mg/kg}$, which achieves full muscarinic receptor blockade).
• Critical Pitfalls and Contraindications:
  • Subtherapeutic Dosing Trap: Doses $< 0.5\text{ mg}$ are strictly avoided because low doses centrally stimulate the vagal nucleus or block presynaptic inhibitory $M_1$ receptors, paradoxically worsening bradycardia.
  • Infranodal Conduction Block: Ineffective in Mobitz II second-degree AV block and complete heart block with wide QRS, as the His-Purkinje system lacks vagal innervation. In these patients, administration of atropine can accelerate the atrial rate without improving ventricular conduction, paradoxically increasing the degree of block.
  • Heart Transplantation: The denervated donor heart has no vagal nerve supply; atropine is completely ineffective and may precipitate paradoxical AV nodal block.
  • Acute Myocardial Ischemia: Excessive atropine-induced tachycardia drastically accelerates myocardial oxygen consumption, exacerbating infarct size.

Second-Line Chronotropic Vasoactive Infusions

When atropine fails, is contraindicated, or while preparing for electrical pacing, initiate continuous intravenous chronotropic infusions:

1. Intravenous Dopamine Infusion: Continuous infusion at $5\text{--}20\mu\text{g/kg/min}$. At $5\text{--}10\mu\text{g/kg/min}$, $\beta_1$-adrenergic stimulation increases heart rate and cardiac contractility. At $> 10\mu\text{g/kg/min}$, $\alpha_1$-adrenergic vasoconstriction increases systemic vascular resistance, elevating blood pressure.
2. Intravenous Epinephrine Infusion: Continuous infusion at $2\text{--}10\mu\text{g/min}$ (or $0.1\text{--}0.5\mu\text{g/kg/min}$). Provides potent direct $\beta_1$ chronotropy, $\beta_1$ inotropy, and $\alpha_1$ systemic vasoconstriction. Highly effective in severe bradycardia accompanied by profound hypotension.
3. Intravenous Isoproterenol Infusion: Continuous infusion at $2\text{--}10\mu\text{g/min}$. Pure non-selective $\beta_1$ and $\beta_2$ adrenergic agonist that markedly accelerates SA nodal discharge and AV conduction without $\alpha$-mediated vasoconstriction. Highly effective in orthotopic heart transplants, beta-blocker toxicity, and pause-dependent Torsades de Pointes. However, $\beta_2$-mediated peripheral vasodilation can worsen hypotension if systemic vascular resistance is already diminished.

Targeted Antidotes for Specific Toxicities

• Beta-Blocker Overdose: High-Dose Insulin Euglycemia Therapy (HIET: regular insulin $1\text{ unit/kg}$ IV bolus, then $0.5\text{--}1.0\text{ unit/kg/hr}$ infusion with dextrose support), intravenous Glucagon ($3\text{--}10\text{ mg}$ slow IV bolus; bypasses adrenergic receptors by directly activating adenylate cyclase), and IV calcium salts.
• Calcium Channel Blocker Overdose: Intravenous calcium chloride ($1\text{--}2\text{ g}$ via central line) or calcium gluconate ($3\text{--}6\text{ g}$), HIET, and vasopressors.
• Digoxin Toxicity: Digoxin-specific Fab antibody fragments (DigiFab; empiric dose 10 to 20 vials for acute cardiac arrest or life-threatening instability).
• Severe Hyperkalemia: Intravenous calcium gluconate ($1\text{--}2\text{ g}$) to stabilize myocardial resting membrane potential, followed by regular insulin, dextrose, nebulized albuterol, and hemodialysis.

---

Transcutaneous Cardiac Pacing (TCP)

Transcutaneous pacing delivers repetitive electrical current across the chest wall to depolarize the myocardium non-invasively, providing an immediate life-saving bridge to transvenous pacing in unstable, atropine-refractory bradycardia.

Electrode Pad Placement

Pad placement directly dictates transthoracic electrical impedance:

• Anterior-Posterior (AP) Configuration (Preferred): The anterior pad is placed over the cardiac apex / left lower parasternal border, and the posterior pad is placed on the back in the left infrascapular area. The AP configuration delivers significantly lower transthoracic impedance, requires lower pacing current (mA), and achieves higher capture rates than anterolateral placement.
• Anterolateral Configuration: Right upper sternal pad and left mid-axillary pad; utilized only when spinal immobilization or patient positioning prevents posterior pad placement.

Procedure and Capture Verification

1. Attach pacing pads and connect ECG monitoring leads. Set pacer mode to Demand (synchronous).
2. Set pacing rate between $60\text{ and }80\text{ bpm}$.
3. Turn pacing current (mA) on at minimum and gradually increase output (typically $50\text{--}100\text{ mA}$, up to $150\text{--}200\text{ mA}$ in hyperinflated or obese patients) until electrical capture is achieved.
4. Electrical Capture on ECG: A distinct, tall pacing spike followed immediately by a widened, bizarre QRS complex ($> 120\text{ ms}$) and a broad, discordant T-wave of opposite polarity.
5. Mechanical Capture Confirmation (CRITICAL):
   • Electrical capture does not equal mechanical cardiac output.
   • Never verify capture using the carotid pulse. Transcutaneous current causes vigorous skeletal muscle contraction of the pectoralis, intercostals, and sternocleidomastoid that mimics a carotid pulsation.
   • True mechanical capture must be verified by palpating the right femoral artery pulse, observing an arterial line pulsatile pressure waveform, or verifying a pulsatile pulse oximeter plethysmograph waveform correlated precisely with the paced rate.
6. Analgesia and Sedation: TCP is excruciatingly painful due to intense chest wall muscle tetany and cutaneous nerve stimulation. Administer intravenous analgesia (fentanyl $25\text{--}50\mu\text{g}$) and sedation (midazolam $1\text{--}2\text{ mg}$ or propofol) as soon as hemodynamic stability is achieved.

---

Temporary Transvenous Pacing (TVP)

Temporary transvenous pacing involves percutaneously advancing a bipolar pacing electrode catheter into the right ventricular endocardium to achieve direct, reliable electrical capture.

Indications for Transvenous Pacing

• Symptomatic high-grade AV block (Mobitz II, complete heart block) refractory to medical management.
• Symptomatic sinus pauses $> 3\text{ seconds}$ or sinus arrest refractory to atropine.
• New alternating bundle branch block or new bifascicular block (e.g., LBBB or RBBB with left anterior/posterior hemiblock) in the setting of acute anterior myocardial infarction.
• Refractory pause-dependent ventricular arrhythmias (overdrive pacing at $90\text{--}110\text{ bpm}$ for Torsades de Pointes).
• Prophylactic standby pacing during pulmonary artery catheter placement in patients with pre-existing LBBB (risk of complete AV block from transient RBBB).

Vascular Access Selection

1. Right Internal Jugular Vein (RIJ; Gold Standard): The anatomical path of choice. Provides the straightest, most direct vertical trajectory through the superior vena cava, right atrium, and tricuspid valve into the RV apex, maximizing catheter stability and minimizing accidental dislodgement.
2. Left Subclavian Vein: Favorable alternative; provides a smooth, gentle anatomic curve through the innominate vein and SVC.
3. Femoral Veins: Third-line route; associated with significantly higher deep venous thrombosis, immobilization, line infection, and frequent catheter dislodgement whenever the patient flexes the hip.

Insertion Technique & Threshold Testing

Under sterile conditions, a $5\text{--}6\text{ French}$ introducer sheath is placed. A balloon-tipped, flow-directed bipolar pacing catheter is advanced into the RV apex:

1. Advance catheter into the right atrium, inflate balloon with $1.5\text{ mL}$ air, and float across the tricuspid valve into the right ventricle. Fluoroscopy or bedside intracardiac ECG monitoring (showing marked ST-segment elevation "injury current" when contacting endocardium) confirms apical placement.
2. Deflate balloon, secure catheter, and connect pins to the external pulse generator (distal electrode to negative terminal [cathode], proximal electrode to positive terminal [anode]).
3. Stimulation (Capture) Threshold Testing:
   • Set pacing rate $10\text{ bpm}$ above intrinsic heart rate.
   • Gradually decrease output current (mA) until electrical capture is lost, then increase until 1:1 capture is restored. This minimum current is the capture threshold.
   • A reliable threshold in the RV apex is $< 1.0\text{ mA}$ (ideally $< 0.5\text{ mA}$). If threshold is $> 1.0\text{ mA}$, the catheter tip is poorly seated and must be gently repositioned.
   • Operational Output Setting: Set the working output to 2 to 3 times the measured capture threshold (or at least $3\text{--}5\text{ mA}$) to provide an adequate safety margin against physiological threshold shifts.
4. Sensitivity Threshold Testing:
   • Sensitivity determines the minimum voltage (mV) the generator must detect to identify an intrinsic ventricular depolarization and inhibit pacing in demand mode (VVI).
   • Measure the intrinsic R-wave amplitude (sensing threshold).
   • Set generator sensitivity to half of the measured sensing threshold (e.g., if intrinsic R-wave is $4\text{ mV}$, set sensitivity to $2\text{ mV}$). Note that a smaller numerical mV setting makes the pacemaker more sensitive; a larger numerical mV setting makes it less sensitive (more "blind").

---

Troubleshooting Pacemaker Malfunctions

When caring for a patient with a temporary transvenous pacemaker, clinicians must rapidly recognize and correct three classic malfunction patterns:

                 TEMPORARY PACING TROUBLESHOOTING
                                 │
         ┌───────────────────────┼───────────────────────┐
         ▼                       ▼                       ▼
  FAILURE TO CAPTURE       UNDERSENSING            OVERSENSING
  • Spike without QRS     • Fires on native QRS   • Missing expected spikes
  • Mechanism: Lead         and T waves (R-on-T)  • Mechanism: Generator too
    dislodgement, high    • Mechanism: Generator    sensitive (detects myo-
    threshold, dead batt    "blind" (mV too high)   potentials / artifact)
  • Action: Max output,   • Action: INCREASE      • Action: DECREASE
    tighten pins, left      SENSITIVITY (turn       SENSITIVITY (turn mV
    lateral decubitus,      mV dial DOWN)           dial UP), switch to
    reposition catheter                             VOO for electrocautery

1. Failure to Capture

• ECG Manifestation: Pacing spikes appear on the rhythm strip at the programmed rate, but are not followed by an evoked QRS complex or T-wave.
• Etiology:
  • Catheter tip dislodgement / displacement from the RV endocardium (most common).
  • Loose wire pin connection in the generator terminals or broken bridging cable.
  • Depleted generator battery.
  • Acute rise in myocardial stimulation threshold: severe hyperkalemia, severe metabolic acidosis, myocardial infarction/ischemia at the electrode contact site, or class Ic / amiodarone toxicity.
  • Right ventricular free wall perforation (pacing catheter punctures through thin RV into pericardial space; manifests as failure to capture, loss of sensing, pericardial friction rub, or cardiac tamponade).
• Immediate Bedside Actions:
  1. Increase generator current output (mA) to maximum.
  2. Check all physical connections: verify pins are firmly seated in correct terminals, ensure cable connections are tight, and replace battery.
  3. Position patient in the left lateral decubitus position, which promotes gravity-assisted contact of the catheter tip against the RV apex.
  4. Obtain immediate bedside echocardiogram and chest X-ray to evaluate catheter position and exclude pericardial effusion/tamponade.
  5. Check and correct serum electrolytes ($K^+$) and arterial blood gases.
  6. If capture cannot be restored, immediately initiate backup transcutaneous pacing or chronotropic infusion while preparing for sterile catheter repositioning.

2. Undersensing (Failure to Sense Native Depolarizations)

• ECG Manifestation: The pacemaker fails to detect the patient's intrinsic R-waves and fires pacing spikes asynchronously during or immediately following native QRS complexes and T-waves.
• Lethal Clinical Hazard: An inappropriately timed pacing spike landing on the peak or downslope of a native T-wave triggers the R-on-T phenomenon, precipitating polymorphic ventricular tachycardia or refractory ventricular fibrillation!
• Etiology: Sensitivity threshold is set too high (the numerical millivolt number is too large, e.g., set to $10\text{ mV}$ when native R-waves are only $3\text{ mV}$, rendering the generator "blind" to native cardiac signals); lead displacement to an area of poor endocardial voltage; low intrinsic R-wave amplitude.
• Immediate Bedside Actions: Increase sensitivity by decreasing the numerical millivolt (mV) setting on the generator dial (e.g., turn down from $5\text{ mV}$ to $1\text{--}2\text{ mV}$). If intrinsic R-wave is chronically $< 1\text{ mV}$, reposition the catheter or switch temporarily to asynchronous VOO mode only if the patient has zero intrinsic ventricular activity.

3. Oversensing (Inappropriate Pacing Inhibition)

• ECG Manifestation: Pacing spikes are absent when expected despite a native heart rate below the programmed pacing rate. The pacemaker appears "dead" or intermittently pauses, resulting in prolonged asystolic pauses and syncope in pacemaker-dependent patients.
• Etiology: The sensitivity threshold is set too low (the numerical millivolt number is too small, e.g., set to $0.5\text{ mV}$, making the pacemaker "hypersensitive"). The generator misinterprets low-voltage non-cardiac electrical signals as intrinsic cardiac depolarizations and inappropriately inhibits pacing. Common culprits include:
  • Pectoral or diaphragmatic skeletal muscle myopotentials (shivering, coughing, deep breathing).
  • Electromagnetic interference (electrocautery during surgery, cell phones, radiofrequency devices).
  • Internal lead wire fracture or loose cable connection generating static artifact.
  • Tall, peaked T-waves or P-waves detected as R-waves.
• Immediate Bedside Actions: Decrease sensitivity by increasing the numerical millivolt (mV) setting on the generator dial (e.g., turn up from $0.5\text{ mV}$ to $2\text{--}4\text{ mV}$) so the pacemaker ignores low-amplitude noise; eliminate external electrical interference; tighten loose connections. In an emergency or during surgical electrocautery in a pacemaker-dependent patient, switch the generator to asynchronous mode (VOO) to prevent fatal asystolic pauses.